Westside Investment Management, Inc. Invitae Corp Transaction History

Westside Investment Management, Inc.

  • $475 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024
SELL
$0.42 - $0.72 $252 - $432
-600 Reduced 75.0%
200 $125,000
Q4 2022

Jan 31, 2023
SELL
$1.71 - $3.61 $513 - $1,083
-300 Reduced 27.27%
800 $1,000
Q2 2021

Jul 28, 2021
BUY
$26.09 - $40.4 $15,654 - $24,240
600 Added 120.0%
1,100 $37,000
Q1 2021

Apr 14, 2021
BUY
$33.06 - $56.93 $16,530 - $28,465
500 New
500 $19,000

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email